Product Introduction

OMNIGAIN MF by Omniceutics is an advanced lipid-based topical hair revitalizing solution formulated with two active pharmaceutical ingredients: Minoxidil 5% w/v and Finasteride 0.1% w/v. It is designed to help manage male pattern hair loss (androgenetic alopecia) through complementary mechanisms that support hair growth and address hormonal factors associated with hair thinning.

The formulation features a lipid-based, alcohol-free solution base and is enhanced with Transcutol P, as stated on the packaging. The product also highlights Smart Peptide Technology, featuring Procapil, Redensyl, Anagain and Burgeon-up as named on the carton.

OMNIGAIN MF is supplied in a convenient 60 ml pack with spray and dropper application options. It is a Schedule H prescription medicine and should be used only under the supervision of a qualified medical practitioner.

Uses

• Management of male pattern hair loss (androgenetic alopecia).

• Helps manage progressive hair thinning associated with androgen-related hair follicle miniaturization.

• Supports hair regrowth in suitable patients with androgenetic alopecia.

• Helps improve hair density and scalp coverage over time when used as prescribed.

Important: This medicine is primarily intended for male pattern hair loss. It is not a general-purpose hair cosmetic or a treatment for every type of hair fall.

Key Ingredients & Full Ingredients

Active Ingredients

Other Formulation Details

• Solution Base: q.s. (quantity sufficient).

• Transcutol P: Highlighted as a formulation enhancer on the front packaging.

• Smart Peptide Technology: Procapil, Redensyl, Anagain and Burgeon-up are named on the packaging.

Ingredient disclosure note: The carton does not provide the complete excipient list or individual concentrations of the peptide-related components. These should not be represented as confirmed ingredients in the complete pharmaceutical composition without manufacturer verification.

Benefits

• Combines Minoxidil and Finasteride in one topical formulation.

• Helps manage male pattern hair loss.

• Supports hair follicle activity and hair growth.

• Helps reduce the effects of DHT-related follicular miniaturization.

• May improve hair density and scalp coverage with consistent prescribed use.

• Lipid-based formulation.

• Alcohol-free formulation as claimed on the packaging.

• Enhanced with Transcutol P.

• Convenient spray and dropper application options.

• 60 ml pack for topical scalp application.

Side Effects

Possible side effects associated with topical Minoxidil and Finasteride include:

Common or relatively frequent effects:

• Scalp irritation or redness.

• Itching and dryness.

• Burning or stinging sensation at the application site.

• Flaking or contact dermatitis.

• Temporary increased hair shedding during the initial treatment period.

• Unwanted facial hair growth if the solution spreads beyond the scalp.

Less common but important effects:

• Dizziness or light-headedness.

• Palpitations or increased heart rate.

• Swelling of the hands, feet or face.

• Chest discomfort.

• Sexual adverse effects associated with Finasteride, including decreased libido and erectile or ejaculation difficulties.

• Breast tenderness or enlargement.

• Mood changes, including depression.

Discontinue use and seek medical advice if serious adverse effects occur. Chest pain, fainting, significant swelling or breathing difficulty require urgent medical assessment.

Product Form

• Dosage Form: Topical Solution

• Formulation Type: Lipid-Based Solution

• Application Route: Topical (scalp)

• Alcohol Status: Alcohol-free, as claimed on packaging

• Pack Size: 60 ml

• Application Options: Spray and Dropper

• Therapeutic Category: Hair Loss Treatment

How to Use

Use only as prescribed by a qualified dermatologist or medical practitioner.

1. Ensure that the hair and scalp are completely dry before application.

2. Open the safety cap.

3. Choose either the spray or dropper application method.

4. Apply the prescribed quantity directly to the affected scalp area.

5. Spread the solution gently over the affected area using fingertips.

6. Avoid contact with eyes, mouth and other sensitive areas.

7. Wash hands thoroughly with soap and water after application.

8. Replace the safety cap after use.

Packaging-specific application instructions:

• Spray method: Prime the spray applicator before first use. The packaging illustrates five sprays for a 1 ml dose.

• Dropper method: Fill the dropper up to the 1 ml marking and apply to the affected scalp area.

The packaging illustrates a 1 ml application quantity. The frequency of application is not clearly specified on the supplied carton. Follow your doctor's prescribed frequency and do not increase the dose independently.

How It Works

1. Minoxidil 5% w/v

Minoxidil is a topical hair growth-promoting medicine. It is believed to work by influencing potassium channels and improving hair follicle activity. It helps prolong the anagen (active growth) phase of the hair cycle and may increase the size of miniaturized hair follicles.

2. Finasteride 0.1% w/v

Finasteride inhibits the type II 5-alpha-reductase enzyme, which converts testosterone into dihydrotestosterone (DHT). Elevated DHT activity contributes to the gradual miniaturization of susceptible scalp hair follicles in androgenetic alopecia. Reducing DHT helps slow this process.

3. Combined Formulation

The combination targets two different mechanisms involved in male pattern hair loss: supporting hair follicle growth and reducing DHT-related follicular miniaturization.

4. Lipid-Based Formulation

The packaging describes a lipid-based, alcohol-free formulation enhanced with Transcutol P. These are formulation characteristics; their clinical impact and comparative absorption should not be assumed without supporting product-specific studies.

3. Medical & Safety Information

Safety Advice

Pregnancy and Breastfeeding

• Finasteride is contraindicated in pregnancy because it can cause abnormalities in the development of external genitalia in a male fetus.

• Women who are pregnant or may become pregnant should not use this product.

• Pregnant women should avoid contact with leaking or damaged containers and the solution itself.

• Breastfeeding women should not use this medicine unless specifically evaluated by a specialist.

Women and Children

• Not intended for use in women or children.

• Keep the medicine out of children's reach.

Alcohol

• No specific direct interaction with alcoholic beverages is established for topical use.

• Avoid excessive alcohol consumption if it contributes to dizziness or other symptoms.

Driving and Operating Machinery

• Topical use is not generally expected to impair driving.

• However, avoid driving if dizziness, faintness or other adverse effects develop.

Heart and Blood Pressure Conditions

• Patients with cardiovascular disease, low blood pressure, high blood pressure or a history of arrhythmia should consult their doctor before use.

• Seek medical attention if chest pain, palpitations or swelling occurs.

Kidney and Liver Conditions

• Inform your doctor about any existing kidney or liver disease before starting treatment.

• Use under medical supervision, particularly if you have other chronic medical conditions.

External Use Only

• Do not swallow.

• Avoid contact with eyes, mouth and broken or irritated skin.

• Do not apply more frequently or in larger quantities than prescribed.

Quick Tips

• Apply only to a clean and completely dry scalp.

• Use consistently according to your dermatologist's instructions.

• Do not wash the treated scalp immediately after application; follow your doctor's advice.

• Wash hands thoroughly after each application.

• Avoid transferring the medicine to other people through direct contact with the treated scalp.

• Do not discontinue treatment or change the dose without medical advice.

• Take standardized scalp photographs periodically to monitor progress.

• Hair growth results generally require several months of consistent treatment.

• Avoid applying to inflamed, infected or damaged scalp skin unless directed by your doctor.

Fact Box

Diet Restrictions: No specific food restrictions are established for topical use. Maintain a balanced diet and adequate nutritional intake.

Interaction with Drugs

Inform your doctor about all medicines and topical preparations you currently use.

Potentially relevant interactions and precautions include:

• Other topical scalp medicines: Concurrent application may increase irritation or alter absorption.

• Other Minoxidil-containing products: Avoid duplicate use or excessive dosing.

• Blood pressure medicines: Systemically absorbed Minoxidil may potentially contribute to blood pressure-related effects.

• Other Finasteride or Dutasteride products: Avoid duplicate 5-alpha-reductase inhibitor treatment unless specifically prescribed.

• Topical corticosteroids and retinoids: May alter skin barrier function and potentially affect absorption or irritation.

• Other scalp treatments: Avoid combining medicated products without professional guidance.

4. Business Details

Manufacturer, Importer and Marketer

Brand Name: OMNIGAIN MF

Marketed By:

OMNICEUTICS HEALTHCARE PVT. LTD.
Plot No. 265/D, Road No. 10, Jubilee Hills,
Hyderabad - 500033, Telangana, India.

Manufactured By:

M/s Samvr Biotech Pvt. Ltd.
An ISO 9001:2015 Certified Company
V&PO Raja Khasa, Tehsil Indora,
Distt. Kangra - 176401,
Himachal Pradesh (INDIA).

Manufacturing Licence Numbers:
NNZ/16-94 & BNZ/2021/160

Batch Details Visible on Packaging:

• Batch No.: SPE260193

• Manufacturing Date: 05/26

• Expiry Date: 04/28

• MRP: ₹1,275.00 (inclusive of all taxes)

• Net Volume: 60 ml / 2.02 fl. oz.

Importer: Not mentioned on the supplied packaging.

Prescription Classification: Schedule H Prescription Drug.

Important Retail Warning: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

5. FAQs

Q1. What is OMNIGAIN MF used for?

OMNIGAIN MF is a prescription topical solution used for managing male pattern hair loss (androgenetic alopecia). It combines Minoxidil 5% and Finasteride 0.1%.

Q2. What are the active ingredients in OMNIGAIN MF?

It contains Minoxidil IP 5% w/v and Finasteride IP 0.1% w/v in a solution base.

Q3. How long does OMNIGAIN MF take to show results?

Visible improvement generally requires several months of consistent treatment. Individual results vary depending on the extent of hair loss, response to treatment and adherence to the prescribed regimen.

Q4. Can OMNIGAIN MF be used by women?

This formulation contains Finasteride and is not intended for women. Finasteride poses a serious risk to the development of a male fetus. Pregnant women should avoid exposure to the medicine.

Q5. Can I stop using OMNIGAIN MF after my hair starts growing?

Do not discontinue treatment without consulting your dermatologist. The benefits of Minoxidil and Finasteride generally require continued treatment, and hair loss may resume after stopping therapy.